Filing Details
- Accession Number:
- 0001144204-13-066827
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-12-12 06:06:36
- Reporting Period:
- 2013-12-11
- Filing Date:
- 2013-12-12
- Accepted Time:
- 2013-12-12 06:06:36
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1001316 | Tg Therapeutics Inc. | TGTX | Pharmaceutical Preparations (2834) | 363898269 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1038977 | S Michael Weiss | 787 Seventh Avenue, 48Th Floor New York NY 10019 | See Remarks | Yes | Yes | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2013-12-11 | 10,000 | $3.43 | 7,839,471 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Footnotes
- Includes 2,236,743 shares of restricted Common Stock, which vest on various time and market capitalization targets. Includes 33,334 warrants to purchase Common Stock at $2.25, exercisable through December 31, 2016. Finally, also included in Mr. Weiss' beneficial ownership are 4,524,560 shares of Common Stock issued to Opus Point Partners, LLC, of which Mr. Weiss is a co-founder, managing partner, and principal and beneficially owns a 50% interest.